UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033430
Receipt number R000038118
Scientific Title Effects of supervised exercise therapy in patients with chronic critical limb ischemia
Date of disclosure of the study information 2018/07/23
Last modified on 2021/01/18 11:38:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of supervised exercise therapy in patients with chronic critical limb ischemia

Acronym

Effects of supervised exercise therapy in patients with chronic CLI

Scientific Title

Effects of supervised exercise therapy in patients with chronic critical limb ischemia

Scientific Title:Acronym

Effects of supervised exercise therapy in patients with chronic CLI

Region

Japan


Condition

Condition

Critical limb ischemia

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of exercise therapy in patients with chronic critical limb ischemia

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Amputation-free survival

Key secondary outcomes

Time to wound healing
6-min walking distance
Changes in limb hemodynamics such as the ABI and peripheral arterial ultrasound examination


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Exercise intervention group

Interventions/Control_2

Non-exercise control group

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Stable CLI patients who underwent endovascular revascularization

Key exclusion criteria

Evidence of active infection
Planned revascularization
Other contraindications for exercise therapy

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Satoru
Middle name
Last name Ohshima

Organization

Kaikoukai Healthcare Corporation, Nagoya Kyoritsu Hospital

Division name

Department of Cardiovascular Medicine

Zip code

467-0033

Address

1-172 Hokke, Nakagawa-ku, Nagoya-shi, Aichi 454-0933, JAPAN

TEL

9099176889

Email

kaku@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Satoru
Middle name
Last name Ohshima

Organization

Kaikoukai Healthcare Corporation, Nagoya Kyoritsu Hospital

Division name

Department of Cardiovascular Medicine

Zip code

454-0933

Address

1-172 Hokke, Nakagawa-ku, Nagoya-shi, Aichi 454-0933, JAPAN

TEL

052-362-5151

Homepage URL


Email

kaku@kaikou.or.jp


Sponsor or person

Institute

Kaikoukai Healthcare Corporation, Nagoya Kyoritsu Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kaikoukai Nagoya Kyoritsu Hospital

Address

1-172 Hokke, Nakagawa

Tel

052-362-5151

Email

kaku@kaikou.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2018 Year 07 Month 19 Day

Date of IRB


Anticipated trial start date

2018 Year 07 Month 23 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 07 Month 18 Day

Last modified on

2021 Year 01 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038118


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name